The evolution of extensively drug resistant tuberculosis (XDR-TB): history, status and issues for global control.

Goldman, Robert C; Plumley, Kevin V; Laughon, Barbara E

Goldman, Robert C; Plumley, Kevin V; Laughon, Barbara E.

Affiliation

Goldman RC; Department of Health and Human Services, National Institute of Allergy and Infectious Diseases, Division of AIDS, Therapeutics Research Program, Complications and Coinfections Research Branch, Bethesda, MD 20892, USA. rgoldman@niaid.nih.gov

Infect Disord Drug Targets ; 7(2): 73-91, 2007 Jun.

Article in En | MEDLINE | ID: mdl-17970220

Subject(s)

Tuberculosis, Multidrug-Resistant/epidemiology; Drug Resistance, Bacterial; HIV Infections/complications; Humans; Models, Theoretical; Mutation; Mycobacterium tuberculosis/drug effects; Mycobacterium tuberculosis/genetics; Mycobacterium tuberculosis/pathogenicity; Tuberculosis, Multidrug-Resistant/prevention & control; Virulence

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant Type of study: Prognostic_studies Limits: Humans Language: En Journal: Infect Disord Drug Targets Journal subject: DOENCAS TRANSMISSIVEIS / TERAPIA POR MEDICAMENTOS Year: 2007 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links